Сравнительная эффективность внутрисуставной инъекции PRP и имплантации гепарин-конъюгированного фибринового гидрогеля при остеоартрозе коленного сустава

Цель исследования. Статья посвящена актуальному направлению современной ортопедии - хирургическому лечению локальных полнослойных дефектов гиалинового хряща коленного сустава. Данная патология диагностируется у 5-10% пациентов с заболеваниями и травмами коленного сустава.
Материалы и методы. Авторы статьи представили одну из самых современных и доступных технологий восстановления хрящевых дефектов - имплантацию гепарин-конъюгированного фибринового гидрогеля. Данная методика операции была выполнена у 38 пациентов. В статье представлены показания и техника операции, критерии оценки результатов лечения.
Результаты и обсуждение. Исходы лечения в сроки до 2 лет изучены у 38 пациентов. Хорошие результаты лечения отмечены у 33 пациентов. Во всех случаях достигнуто качественное восстановление и регенерация хрящевой поверхности мыщелков бедренной кости.
Заключение. Анализ результатов лечения пациентов после имплантации гепарин-конъюгированного фибринового гидрогеля позволяет авторам статьи рекомендовать данную методику к широкому применению в клинической практике.

1. Adult stem cells in bone and cartilage tissue engineering /A. J. Salgado, J. T. Oliveira, A. J. Pedro, R. L. Reis //Curr. Stem. Cell. Res. Ther. – 2006. – V. 1 (3). – P. 345-364.

2. Bozhokin M. S. Possibilities of modern cellular technologies for the restoration of damaged articular cartilage (analytical review of the literature) /M. S. Bozhokin, S. A. Bozhkova, G. I. Netylko // Traumatology and Orthopedics of Russia. – 2016. – V. 3. – P. 122-134.

3. Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow /A. Sasaki, M. Mizuno, N. Ozeki et al. // PLoS One. – 2018. – V. 13 (8). – e0202922.

4. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors /C. Vinatier, D. Mrugala, C. Jorgensen et al. //Trends Biotechnol. – 2009. – V. 27 (5). – P. 307-314.

5. Chimutengwende-Gordon M. Current solutions for the treatment of chronic articular cartilage defects in the knee /M. Chimutengwende-Gordon, J. Donaldson, G. Bentley //EFORT Open Rev. – 2020. – V. 5 (3). – P. 156-163.

6. Combinations of Hydrogels and Mesenchymal Stromal Cells (MSCs) for Cartilage Tissue Engineering-A Review of the Literature /M. Wagenbrenner, S. Mayer-Wagner, M. Rudert //Gels. – 2021. – V. 7 (4). – P. 217.

7. Ding D. C. Mesenchymal stem cells /D. C. Ding, W. C. Shyu, S. Z. Lin //Cell Transplant. – 2011. – V. 20 (1). – P. 5-14.

8. Garkavi A. V. Arthroscopic chondroplasty of local cartilaginous defects of the knee joint using the chondrogide collagen membrane /A. V. Garkavi, M. Yu. Blokov //Traumatology and Orthopedics. – 2015. – V. 3 (15). – P. 4-7.

9. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 /S. Safiri, A. A. Kolahi, E. Smith et al. //Ann. Rheum. Dis. – 2020. – V. 79 (6). – P. 819-828.

10. Heparin-Conjugated Fibrin Hydrogel with Chondroinductive Growth Factors and Human Synovium-Derived Mesenchymal Stem Cells for the Treatment of Articular Cartilage Defects: Evaluation of Clinical Safety /T. A. Toktarov, B. N. Saginov, Y. K. Raimagambetov //International Journal of Biomedicine. – 2022. – V. 12 (4). – P. 539-547.

11. Hiligsmann M. The economic weight of osteoarthritis in Europe /M. Hiligsmann, J. Y. Reginster //J. Medicographia. – 2013. – V. 35. – P. 197-202.

12. Hoffman J. K. Articular cartilage repair using marrow stimulation augmented with a viable chondral allograft: 9-month postoperative histological evaluation /J. K. Hoffman, S. Geraghty, N. M. Protzman //Case Rep. Orthop. – 2015. – V. 2015. – 617365.

13. Huang B. J.Cell-based tissue engineering strategies used in the clinical repair of articular cartilage /B. J. Huang, J. C. Hu, K. A. Athanasiou // Biomaterials. - 2016. – V. 98. – P. 1-22.

14. Huselstein C. Mesenchymal stem cells for cartilage engineering /C. Huselstein, Y. Li, X. He // Biomed. Mater. Eng. – 2012. – V. 22 (1-3). – P. 69-80.

15. Jones B. A. Synovium-derived stem cells: a tissuespecific stem cell for cartilage engineering and regeneration /B. A. Jones, M. Pei //Tissue Eng. Part. B. Rev. – 2012. – V. 18 (4). – P. 301-311.

16. Knee articular cartilage repair and restoration techniques: a review of the literature /D. L. Richter, R. C. Schenck Jr, D. C. Wascher, G. Treme //Sports Health. – 2016. – V. 8 (2). – P. 153-160.

17. Koga H. Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration /H. Koga, T. Muneta, Y. J. Ju //Stem Cells. – 2007. – V. 25 (3). – P. 689-696.

18. Kushner F. D. Knee Surgery /F. D. Kushner, V. N. Scott, J. R. Scuderi – Moscow: Medical Literature, 2014. – 274 p.

19. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? /Y. S. Kim, Y. J. Choi, D. S. Suh et al. //Am. J. Sports. Med. – 2015. – V. 43 (1). – P. 176-185.

20. Mesenchymal stem cell therapy to rebuild cartilage /D. Magne, C. Vinatier, M. Julien et al. // Trends Mol. Med. – 2005. – V. 11 (11). – P. 519-526.

21. Outcome of autologous matrix induced chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry /J. Gille, P. Behrens, P. Volpi, et al. //Arch. Orthop. Trauma Surg. – 2013. – V. 133 (1). – P. 87-93.

22. Patent of the Republic of Kazakhstan. A method for obtaining an injectable biocomposite hydrogel to stimulate the regeneration of bone and cartilage tissue /V. B. Ogay, A. S. Isabekova, M. A. Sarsenova, E. M. Ramankulov. 2019; 33784: 29.

23. Ridley T. J. Patellofemoral articulating osteochondral (Kissing) lesion treated with autologous chondrocyte implantation: a case report /T. J. Ridley, C. T. Rud, J. A. Macalena //J. Orthop. Case. Rep. – 2017. – V. 7 (3). – P. 41-44.

24. Scaffold-based repair for cartilage healing: a systematic review and technical note /G. Filardo, E. Kon, A. Roffi, A. Di Martino et al. //Arthroscopy. – 2013. – V. 29 (1). – P. 174-186.

25. Synoviumderived mesenchymal stem cells: a new cell source for musculoskeletal regeneration /J. Fan, R. R. Varshney, L. Ren et al. //Tissue Eng. Part. B. Rev. – 2009. – V. 15 (1). – P. 75-86.

26. The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results /A. M. Haleem, A. A. Singergy, D. Sabry et al. //Cartilage. – 2010. – V. 1 (4). – P. 253-261.

27. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years /A. Klug, Y. Gramlich, M. Rudert et al. //Knee Surg. Sports Traumatol. Arthrosc. – 2021. – V. 29 (10). – P. 3287-3298.